J A Franciosa, E D Freis, J Conway. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Administration, OralAdrenergic beta-Antagonists/administration & dosageAdrenergic beta-Antagonists/pharmacologyAdrenergic beta-Antagonists/therapeutic useAmino Alcohols/administration & dosageAmino Alcohols/pharmacologyAmino Alcohols/therapeutic useAntihypertensive Agents/administration & dosageAntihypertensive Agents/pharmacologyAntihypertensive Agents/therapeutic useBlood Pressure/drug effectsButylamines/administration & dosageButylamines/pharmacologyButylamines/therapeutic useCardiac OutputHeart Rate/drug effectsHemodynamics/drug effectsHumansHypertension/drug therapyMaleMiddle AgedMorpholines/administration & dosageMorpholines/pharmacologyMorpholines/therapeutic usePropranolol/pharmacologyPropranolol/therapeutic useThiadiazoles/administration & dosageThiadiazoles/pharmacologyThiadiazoles/therapeutic useValsalva ManeuverVascular Resistance/drug effects
Substances: See more » Adrenergic beta-AntagonistsAmino AlcoholsAntihypertensive AgentsButylaminesMorpholinesThiadiazolesPropranolol
Year: 1973 PMID: 4150000 DOI: 10.1161/01.cir.48.1.118
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690